Pharma IQ: How has the global serialisation landscape evolved in recent years?
P Kemppainen: It has gotten more complicated after the introduction of first markets, like China, Turkey and now Korea, and it’s evolving, unfortunately, in the same direction. Basically all the markets requiring serialisation are have diversified and have different expectations and requirements.
I would say that from the pharma manufacturer point of view, the challenge is that how do you keep...
To continue reading this story Click Here
RECOMMENDED
Upcoming Events
DigIT Pharma & Health 2024
September 10 - 12, 2024
Düsseldorf, Germany
Register Now |
View Agenda |
Learn More
Temperature Control and Logistics North America Summit
September 10 - 12, 2024
Falls Church, VA
Register Now |
View Agenda |
Learn More